These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 23296792
21. FGF-23 in children with CKD: a new player in the development of CKD-mineral and bone disorder. Siomou E, Stefanidis CJ. Nephrol Dial Transplant; 2012 Dec; 27(12):4259-62. PubMed ID: 22848110 [Abstract] [Full Text] [Related]
22. Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis. Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, Landray MJ, Moe SM, Yang J, Holland L, di Giuseppe R, Bouma-de Krijger A, Mihaylova B, Herrington WG. J Am Soc Nephrol; 2018 Jul; 29(7):2015-2027. PubMed ID: 29764921 [Abstract] [Full Text] [Related]
23. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Circulation; 2009 May 19; 119(19):2545-52. PubMed ID: 19414634 [Abstract] [Full Text] [Related]
24. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis. Seeherunvong W, Abitbol CL, Chandar J, Rusconi P, Zilleruelo GE, Freundlich M. Pediatr Nephrol; 2012 Nov 19; 27(11):2129-2136. PubMed ID: 22710695 [Abstract] [Full Text] [Related]
25. Fibroblast growth factor-23 and cardiovascular events in CKD. Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, Kusek JW, Feldman H, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. J Am Soc Nephrol; 2014 Feb 19; 25(2):349-60. PubMed ID: 24158986 [Abstract] [Full Text] [Related]
30. [Biological activity of FGF-23 and pathophysiologic role in chronic kidney disease]. Yamashita T. Clin Calcium; 2004 May 19; 14(5):760-3. PubMed ID: 15577039 [Abstract] [Full Text] [Related]
31. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients. Mizuiri S, Nishizawa Y, Yamashita K, Ono K, Oda M, Usui K, Shigemoto K. Nephrology (Carlton); 2014 Sep 19; 19(9):568-73. PubMed ID: 24947687 [Abstract] [Full Text] [Related]
32. Acid Load and Phosphorus Homeostasis in CKD. Khairallah P, Isakova T, Asplin J, Hamm L, Dobre M, Rahman M, Sharma K, Leonard M, Miller E, Jaar B, Brecklin C, Yang W, Wang X, Feldman H, Wolf M, Scialla JJ, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Am J Kidney Dis; 2017 Oct 19; 70(4):541-550. PubMed ID: 28645705 [Abstract] [Full Text] [Related]
38. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE]. Milovanova LY, Kozlovskaya LV, Markina MM, Milovanova SY, Borisov AA, Mukhin NA, Fomin VV, Moiseev SV. Klin Med (Mosk); 2015 Oct 19; 93(12):32-8. PubMed ID: 27149811 [Abstract] [Full Text] [Related]
39. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study. Deo R, Katz R, de Boer IH, Sotoodehnia N, Kestenbaum B, Mukamal KJ, Chonchol M, Sarnak MJ, Siscovick D, Shlipak MG, Ix JH. Am J Kidney Dis; 2015 Jul 19; 66(1):40-6. PubMed ID: 25572028 [Abstract] [Full Text] [Related]
40. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients. Bech AP, Bouma-de Krijger A, van Zuilen AD, Bots ML, van den Brand JA, Blankestijn PJ, Wetzels JF, Vervloet MG. J Nephrol; 2015 Aug 19; 28(4):477-84. PubMed ID: 25700931 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]